AI English summary of an SEC filing — figures as filed
Labcorp said it will release its Q2 2025 financial results before the market opens on Thursday, July 24, 2025.
Key points
AI summaryLabcorp said it will release its Q2 2025 financial results before the market opens on Thursday, July 24, 2025.
The company said it will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. It said the earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
The company said the webcast and dial-in are listen-only and recommended that participants join 10 minutes before the start. A replay of the webcast will be available approximately two hours after the live event ends and until July 11, 2026.
The company said in its boilerplate that it has nearly 70,000 employees serving clients in approximately 100 countries. It also said it provided support for more than 75% of the new drugs and therapeutic products approved by the FDA in 2024 and performs more than 700 million tests annually.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q2 2025 Earnings Release Date and Time
Labcorp said it will release its Q2 2025 financial results before the market opens on Thursday, July 24, 2025.
Source · Based on the filing body and exhibits
Earnings Call and Webcast Schedule
The company said it will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. It said the earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Source · Based on the filing body and exhibits
Webcast Access and Replay Period
The company said the webcast and dial-in are listen-only and recommended that participants join 10 minutes before the start. A replay of the webcast will be available approximately two hours after the live event ends and until July 11, 2026.
Source · Based on the filing body and exhibits
Scale Cited in Company Description
The company said in its boilerplate that it has nearly 70,000 employees serving clients in approximately 100 countries. It also said it provided support for more than 75% of the new drugs and therapeutic products approved by the FDA in 2024 and performs more than 700 million tests annually.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…